Loading provider…
Loading provider…
Radiation Oncology Physician in Ann Arbor, MI
NPI: 1740464627Primary Practice Location
UNIVERSITY OF MICHIGAN HEALTH SYSTEM
1540 E Hospital Dr, Ann Arbor, MI
Primary Employer
Regents of the University of Michigan
michiganmedicine.org
HQ Phone
Get MD Kyle's Phone Numberphone_androidMobile
Get MD Kyle's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardMI State Medical License
TN State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 77263Complex radiation therapy planning | 61 | 77 |
| 2 | 77427Radiation treatment management, 5 treatment sessions | 47 | 101 |
| 3 | 99205New patient office or other outpatient visit, typically 60 minutes | 42 | 42 |
| 4 | 77300Calculation of radiation therapy dose | 39 | 151 |
| 5 | 77332Design and construction of simple radiation treatment device | 37 | 87 |
Role of Stereotactic Body Radiation Therapy in Oligometastatic Sarcoma.
Authors: @ValidYN, LastName, ForeName, Initials, AffiliationInfo
Journal: Cancer J
Salary and Resources Provided to Junior Faculty in Radiation Oncology.
Authors: Lalani, Nafisha, Griffith, Kent A, Jones, Rochelle D, Cuneo, Kyle, Jagsi, Reshma
Journal: Int J Radiat Oncol Biol Phys
Publication Date: 2018-09-18
Pretreatment Levels of Soluble Tumor Necrosis Factor Receptor 1 and Hepatocyte Growth Factor Predict Toxicity and Overall Survival After 90Y Radioembolization: Potential Novel Application of Biomarkers for Personalized Management of Hepatotoxicity.
Authors: Ravi Kaza, Matthew Cousins
Publication Date: 2021-04-16
Lead Sponsor: ECOG-ACRIN Cancer Research Group
Collaborators: National Cancer Institute (NCI)
Intervention / Treatment: PROCEDURE: Magnetic Resonance Imaging, OTHER: Questionnaire Administration, OTHER: Fludeoxyglucose F-18, PROCEDURE: Positron Emission Tomography, PROCEDURE: Biospecimen Collection, DRUG: Capecitabine, OTHER: Quality-of-Life Assessment, DRUG: Fluorouracil, RADIATION: Intensity-Modulated Radiation Therapy, PROCEDURE: Computed Tomography, PROCEDURE: Biopsy, DRUG: Mitomycin
Lead Sponsor: National Cancer Institute (NCI)
Collaborators: NRG Oncology
Intervention / Treatment: BIOLOGICAL: Pembrolizumab, DRUG: Capecitabine, DRUG: Fluorouracil, DRUG: Veliparib, RADIATION: Intensity-Modulated Radiation Therapy, DRUG: Oxaliplatin, DRUG: Leucovorin
Lead Sponsor: University of Michigan Rogel Cancer Center
Collaborators: National Institutes of Health (NIH)
Intervention / Treatment: RADIATION: Adaptive Radiation Therapy